👉🏿Les lignes directrices concernant le traitement médical de la maladie de Crohn luminale chez l’enfant ont été publiées récemment dans la revue Gastroenterology et la revue Journal of the Canadian Association of Gastroenterology.
Lisez et Partagez
https://www.gastrojournal.org/article/S0016-5085(19)33577-2/pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6619414/
Samedi 27 et dimanche 28 avril 2019 : Défi Caritatif Banque Scotia 21Km et 5Km.
In this multi-center study (@ChuSteJustine @HopitalChildren @BCCHF @HopRobertDebre), we found that children living with #crohnsdisease who failed at least 1 antiTNF, had at 12 months,
38.6% clinical remission
47.8% clinical response
with #ustekinumab
#Jantchoulab
Heureux d’avoir obtenu ce financement des Instituts de recherche en santé du Canada (IRSC) IRSC qui nous permettra en collaboration avec ma consœur Dr Marie-Claude Rousseau de INRS – Armand Frappier de mener notre projet concernant les facteurs de risques associés aux Maladies Inflammatoires Intestinales.
http://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=380766&lang=fr
Inflammatory bowel disease is a chronic disease of the gut. It affects digestion and absorption of food, and elimination of waste. Its causes are unknown. After many studies, researchers have only been able to identify a few risk factors with certainty. They include family history of the disease and cigarette smoking.
The causes of this disease are still unknown, but some researchers think that certain times in life could be more critical for the development of the disease. Our goal is to clarify the causes of disease, and identify which ones could be targeted by prevention program.
We will study medical, lifestyle, and psychosocial factors from the time of birth until adult years. We will determine if they are linked to the development of the disease. These factors are for example prematurity, breastfeeding, antibiotic use, diet, smoking, stress. We will also study carefully when these factors occur during a person’s life.
For this research, we will use a cohort of about 400,000 persons born between 1970 and 1974, in the province of Quebec, Canada. We created this cohort for a previous study by linking together some provincial administrative databases. Data on medical services and hospitalizations for inflammatory bowel disease were obtained until 2014 and will be used to determine who is affected by the disease.
Then, we will ask about 2600 persons of the cohort to complete a web survey to obtain additional information. Among the participants, we will compare persons who have the disease to those who do not, and evaluate what are the key moments throughout their lives when these factors could increase the risk of the disease.
This research will help understanding which factors increase the risk of inflammatory bowel disease by detecting if there are certain times in a person’s life that are especially important. We will produce crucial information to establish prevention programs.
La cinquième édition du congrès mondial de gastro-entérologie pédiatrique aura lieu à Montréal du 5 au 8 octobre 2016.
Plusieurs experts gastro-entérologue hépatologues et nutritionnistes pédiatres du monde entier se donnent rendez-vous pour cet événement qui se tient tous les quatre dans divers continents. Il s’agit de la deuxième année où cela a lieu dans le continent américain.
Notre laboratoire de recherche présentera plusieurs des travaux lors de ce congrès : Liste ci-dessous
Quality indicators in pediatric digestive endoscopy: lessons learned from a high volume endoscopy unit.
Anne-Sophie Groleau … Prévost Jantchou
Oral presentation
Endoscopy Imaging
Saturday, October 8, 2016.
16:00PM
Development and validation of a satisfaction questionnaire for pediatric digestive endoscopy .
Mélissandre Ostiguy …Prévost Jantchou
poster number 109
Friday, October 7, 2016
Usefulness of a pediatric infalmmatory bowel disease database for nurse follow-up of a big cohort.
poster number 19.
Friday, October 7, 2016 and Saturday, October 8, 2016.
France Gervais…Prévost Jantchou
Building a clinical and research database for children with inflammatory bowel disease (pedidata) : a step-by-step process.
Prévost Jantchou
Thursday, October 6, 2016.
poster number 252.
Phenotypic caracterization, indication and outcome of children with inflammatory bowel disease receiving blood transfusion.
Arafa Djalal…Prévost Jantchou
Friday, October 7, 2016
Outcome at 8 weeks of children treated with exclusive enteral nutrition (Modulen).
Amélie Roch…Prévost Jantchou
Poster number 229
Friday, October 7, 2016
Therapeutic drug monitoring is a new tool for improving the care of patients treated for Inflammatory bowel disease
Mallory Chavannes… Prevost Jantchou
Thursday, October 6, 2016.
Poster number 235
Rejoignez nous pour cette belle fête scientifique.
http://www.wcpghan2016.com/scientific-programme.html
How @evernote helped me take notes and organize my ideas during last @ddwmeeting in @washington. Very useful for #DDW15 and tips for #DDW16.
The Vitamin D in Pediatric Crohn’s Disease is multicentric Randomized Controlled Trial of High Dose Vitamin D in Children With Newly Diagnosed Crohn’s Disease for the Prevention of Relapses. https://clinicaltrials.gov/ct2/show/record/NCT02186275
————————-
This study have been approved by Health Canada and is supported by the Canadian Children Inflammatory Bowel Disease Network (CiDSCANN) and Crohn’s and Colitis Canada.
Building a database for inflammatory bowel disease:
Here are the three parts video of the webinar about building a database for IBD
PART1: Why, How and when
Part 2: Live Demo
Part 3: Security and Filemaker server
